These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24021800)

  • 21. Dual-specificity tyrosine-phosphorylated and regulated kinase 1A (DYRK1A) interacts with the phytanoyl-CoA alpha-hydroxylase associated protein 1 (PAHX-AP1), a brain specific protein.
    Bescond M; Rahmani Z
    Int J Biochem Cell Biol; 2005 Apr; 37(4):775-83. PubMed ID: 15694837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome.
    Park J; Yang EJ; Yoon JH; Chung KC
    Mol Cell Neurosci; 2007 Oct; 36(2):270-9. PubMed ID: 17720532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease.
    Wong H; Levenga J; Cain P; Rothermel B; Klann E; Hoeffer C
    Acta Neuropathol; 2015 Dec; 130(6):829-43. PubMed ID: 26497675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).
    Song WJ; Song EA; Jung MS; Choi SH; Baik HH; Jin BK; Kim JH; Chung SH
    J Biol Chem; 2015 Jan; 290(4):2321-33. PubMed ID: 25477508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperation to amplify gene-dosage-imbalance effects.
    de la Luna S; Estivill X
    Trends Mol Med; 2006 Oct; 12(10):451-4. PubMed ID: 16919501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.
    Jin N; Yin X; Gu J; Zhang X; Shi J; Qian W; Ji Y; Cao M; Gu X; Ding F; Iqbal K; Gong CX; Liu F
    J Biol Chem; 2015 Jun; 290(24):15219-37. PubMed ID: 25918155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles.
    Murakami N; Bolton D; Hwang YW
    Biochemistry; 2009 Oct; 48(39):9297-305. PubMed ID: 19722700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.
    Melchior B; Mittapalli GK; Lai C; Duong-Polk K; Stewart J; Güner B; Hofilena B; Tjitro A; Anderson SD; Herman DS; Dellamary L; Swearingen CJ; Sunil KC; Yazici Y
    Aging Cell; 2019 Oct; 18(5):e13000. PubMed ID: 31267651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice.
    Liu C; Zheng L; Wang H; Ran X; Liu H; Sun X
    Cell Death Dis; 2015 Oct; 6(10):e1929. PubMed ID: 26492364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors.
    Czarna A; Wang J; Zelencova D; Liu Y; Deng X; Choi HG; Zhang T; Zhou W; Chang JW; Kildalsen H; Seternes OM; Gray NS; Engh RA; Rothweiler U
    J Med Chem; 2018 Sep; 61(17):7560-7572. PubMed ID: 30095246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
    Sitz JH; Baumgärtel K; Hämmerle B; Papadopoulos C; Hekerman P; Tejedor FJ; Becker W; Lutz B
    Neuroscience; 2008 Dec; 157(3):596-605. PubMed ID: 18938227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.
    De la Torre R; De Sola S; Pons M; Duchon A; de Lagran MM; Farré M; Fitó M; Benejam B; Langohr K; Rodriguez J; Pujadas M; Bizot JC; Cuenca A; Janel N; Catuara S; Covas MI; Blehaut H; Herault Y; Delabar JM; Dierssen M
    Mol Nutr Food Res; 2014 Feb; 58(2):278-88. PubMed ID: 24039182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1.
    Park J; Oh Y; Chung KC
    BMB Rep; 2009 Jan; 42(1):6-15. PubMed ID: 19192387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways.
    Liu H; Wang P; Song W; Sun X
    FASEB J; 2009 Oct; 23(10):3383-92. PubMed ID: 19509306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation, regulation, and inhibition of DYRK1A.
    Becker W; Sippl W
    FEBS J; 2011 Jan; 278(2):246-56. PubMed ID: 21126318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid-β precursor protein facilitates the regulator of calcineurin 1-mediated apoptosis by downregulating proteasome subunit α type-5 and proteasome subunit β type-7.
    Wu Y; Deng Y; Zhang S; Luo Y; Cai F; Zhang Z; Zhou W; Li T; Song W
    Neurobiol Aging; 2015 Jan; 36(1):169-77. PubMed ID: 25194880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-performance liquid chromatography assay for Dyrk1a, a Down syndrome-associated kinase.
    Bui LC; Tabouy L; Busi F; Dupret JM; Janel N; Planque C; Delabar JM; Rodrigues-Lima F; Dairou J
    Anal Biochem; 2014 Mar; 449():172-8. PubMed ID: 24374000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A hidden incoherent switch regulates RCAN1 in the calcineurin-NFAT signaling network.
    Shin SY; Yang HW; Kim JR; Heo WD; Cho KH
    J Cell Sci; 2011 Jan; 124(Pt 1):82-90. PubMed ID: 21172821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.